File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Acute calcitriol treatment mitigates vitamin D deficiency-associated mortality after intracerebral haemorrhage

TitleAcute calcitriol treatment mitigates vitamin D deficiency-associated mortality after intracerebral haemorrhage
Authors
KeywordsBlood–brain barrier
Intracerebral haemorrhage
Neuroinflammation
Neuroprotection
Vitamin D deficiency
Issue Date8-Aug-2024
PublisherElsevier
Citation
Neuroscience Letters, 2024, v. 838 How to Cite?
Abstract

Objective: Vitamin D deficiency (VDD) is emerging as a predictor of poor prognosis in various neurological conditions, where clinical outcomes are often worse in stroke patients with VDD. This study aimed to provide experimental evidence on whether and how pre-existing VDD would affect survival and neurofunctional outcomes in intracerebral haemorrhage (ICH), and to evaluate whether acute vitamin D (VD) supplementation would improve post-stroke outcomes. Methods: Experimental ICH models were induced in mice with and without VDD. Haematoma size was measured using T2*-weighted MRI and haemoglobin concentration. Post-ICH mortality, neurofunctional outcomes and the extent of blood–brain barrier (BBB) leakage were assessed to identify their correlations with VD status. Therapeutic benefits of acute VD administration were also evaluated. Results: Mice with VDD exhibited significantly higher acute mortality rates and more severe motor deficits than mice without VDD post-ICH. Marked haematoma expansion and increased Evans blue extravasation were observed in VDD mice, suggesting that VDD was associated outcomes with increased BBB disruption. Acute treatment with a loading dose of VD (calcitriol) significantly improved outcomes in VDD mice. Conclusion: This study provides novel insights into the pathophysiological mechanisms at play in ICH concomitant with VDD and a scientific rationale for acute treatment with VD.


Persistent Identifierhttp://hdl.handle.net/10722/351802
ISSN
2023 Impact Factor: 2.5
2023 SCImago Journal Rankings: 0.745

 

DC FieldValueLanguage
dc.contributor.authorChan, Andrian A-
dc.contributor.authorLam, Tsz Lung-
dc.contributor.authorLiu, Jiaxin-
dc.contributor.authorNg, Anson Cho-Kiu-
dc.contributor.authorZhang, Cuiting-
dc.contributor.authorKiang, Karrie M-
dc.contributor.authorLeung, Gilberto Ka-Kit-
dc.date.accessioned2024-11-30T00:35:05Z-
dc.date.available2024-11-30T00:35:05Z-
dc.date.issued2024-08-08-
dc.identifier.citationNeuroscience Letters, 2024, v. 838-
dc.identifier.issn0304-3940-
dc.identifier.urihttp://hdl.handle.net/10722/351802-
dc.description.abstract<p>Objective: Vitamin D deficiency (VDD) is emerging as a predictor of poor prognosis in various neurological conditions, where clinical outcomes are often worse in stroke patients with VDD. This study aimed to provide experimental evidence on whether and how pre-existing VDD would affect survival and neurofunctional outcomes in intracerebral haemorrhage (ICH), and to evaluate whether acute vitamin D (VD) supplementation would improve post-stroke outcomes. Methods: Experimental ICH models were induced in mice with and without VDD. Haematoma size was measured using T2*-weighted MRI and haemoglobin concentration. Post-ICH mortality, neurofunctional outcomes and the extent of blood–brain barrier (BBB) leakage were assessed to identify their correlations with VD status. Therapeutic benefits of acute VD administration were also evaluated. Results: Mice with VDD exhibited significantly higher acute mortality rates and more severe motor deficits than mice without VDD post-ICH. Marked haematoma expansion and increased Evans blue extravasation were observed in VDD mice, suggesting that VDD was associated outcomes with increased BBB disruption. Acute treatment with a loading dose of VD (calcitriol) significantly improved outcomes in VDD mice. Conclusion: This study provides novel insights into the pathophysiological mechanisms at play in ICH concomitant with VDD and a scientific rationale for acute treatment with VD.</p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofNeuroscience Letters-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectBlood–brain barrier-
dc.subjectIntracerebral haemorrhage-
dc.subjectNeuroinflammation-
dc.subjectNeuroprotection-
dc.subjectVitamin D deficiency-
dc.titleAcute calcitriol treatment mitigates vitamin D deficiency-associated mortality after intracerebral haemorrhage-
dc.typeArticle-
dc.identifier.doi10.1016/j.neulet.2024.137922-
dc.identifier.scopuseid_2-s2.0-85201269579-
dc.identifier.volume838-
dc.identifier.eissn1872-7972-
dc.identifier.issnl0304-3940-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats